Show simple item record

TOPARP-B: A phase II randomised trial of the poly(ADP)-ribose polymerase (PARP)inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations

dc.contributor.authorMateo, J
dc.contributor.authorPorta, N
dc.contributor.authorMcGovern, U
dc.contributor.authorElliott, Tony
dc.contributor.authorJones, R
dc.contributor.authorSyndikus, I
dc.contributor.authorRalph, C
dc.contributor.authorJain, S
dc.contributor.authorVarughese, M
dc.contributor.authorParikh, O
dc.contributor.authorCrabb, S
dc.contributor.authorRobinson, A
dc.contributor.authorMcLaren, D
dc.contributor.authorBirtle, A
dc.contributor.authorTanguay, J
dc.contributor.authorMiranda, S
dc.contributor.authorSeed, G
dc.contributor.authorBertan, C
dc.contributor.authorEspinasse, A
dc.contributor.authorChatfield, P
dc.contributor.authorBianchini, D
dc.contributor.authorHall, E
dc.contributor.authorCarreira, S
dc.contributor.authorDe Bono, J
dc.date.accessioned2020-01-29T15:17:54Z
dc.date.available2020-01-29T15:17:54Z
dc.date.issued2019en
dc.identifier.citationMateo J, Porta N, McGovern U, Elliott T, Jones R, Syndikus I, et al. TOPARP-B: A phase II randomised trial of the poly(ADP)-ribose polymerase (PARP)inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterations. British Journal of Cancer. 2019;121:25en
dc.identifier.urihttp://hdl.handle.net/10541/622704
dc.language.isoenen
dc.titleTOPARP-B: A phase II randomised trial of the poly(ADP)-ribose polymerase (PARP)inhibitor olaparib for metastatic castration resistant prostate cancers (mCRPC) with DNA damage repair (DDR) alterationsen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentVall dÕHebron Institute of Oncology, Barcelona, Spainen
dc.identifier.journalBritish Journal of Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record